4/21
07:55 am
slp
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
Medium
Report
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
4/20
07:55 am
slp
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School
Medium
Report
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School
4/19
05:00 pm
slp
Here's Simulations Plus Inc (SLP)'s Vision for AI in Drug Development [Yahoo! Finance]
Medium
Report
Here's Simulations Plus Inc (SLP)'s Vision for AI in Drug Development [Yahoo! Finance]
4/15
12:20 pm
slp
Simulations Plus: Better Quarter, Same Doubts [Seeking Alpha]
Low
Report
Simulations Plus: Better Quarter, Same Doubts [Seeking Alpha]
4/10
11:25 am
slp
Simulations Plus (SLP) had its price target lowered by TD Cowen from $19.00 to $16.00. They now have a "hold" rating on the stock.
Low
Report
Simulations Plus (SLP) had its price target lowered by TD Cowen from $19.00 to $16.00. They now have a "hold" rating on the stock.
4/9
04:53 pm
slp
Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results [Yahoo! Finance]
High
Report
Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results [Yahoo! Finance]
4/9
04:13 pm
slp
Simulations Plus Non-GAAP EPS of $0.35 beats by $0.05, revenue of $24.3M beats by $2.64M [Seeking Alpha]
High
Report
Simulations Plus Non-GAAP EPS of $0.35 beats by $0.05, revenue of $24.3M beats by $2.64M [Seeking Alpha]
4/9
04:05 pm
slp
Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results
Medium
Report
Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results
4/4
01:04 am
slp
Low
Report
3/31
09:00 am
slp
Simulations Plus, Inc. Investigated by the Portnoy Law Firm
Medium
Report
Simulations Plus, Inc. Investigated by the Portnoy Law Firm
3/30
11:11 pm
slp
???????????????????2036??54.9??????CAGR7.98%??????????????????? [CNET News]
Medium
Report
???????????????????2036??54.9??????CAGR7.98%??????????????????? [CNET News]
3/27
07:08 am
slp
Simulations Plus and three pharma companies collaborate on AI-driven drug development [Yahoo! Finance]
Low
Report
Simulations Plus and three pharma companies collaborate on AI-driven drug development [Yahoo! Finance]
3/26
04:05 pm
slp
Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date
Low
Report
Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date
3/26
07:55 am
slp
Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling
Low
Report
Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling
3/3
07:03 pm
slp
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD [Yahoo! Finance]
Low
Report
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD [Yahoo! Finance]
3/3
07:55 am
slp
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD
Low
Report
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD
2/26
08:53 am
slp
How an Ecosystem-Driven Electronic Lab Notebook (ELN) Accelerates R&D, Upcoming Webinar Hosted by Xtalks [Yahoo! Finance]
Low
Report
How an Ecosystem-Driven Electronic Lab Notebook (ELN) Accelerates R&D, Upcoming Webinar Hosted by Xtalks [Yahoo! Finance]
2/10
02:37 pm
slp
SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Low
Report
SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
2/9
06:45 pm
slp
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations
Low
Report
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations
2/8
12:51 pm
slp
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
Low
Report
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
2/5
07:40 pm
slp
SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Medium
Report
SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
2/4
06:44 am
slp
Simulations Plus (NASDAQ:SLP) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Simulations Plus (NASDAQ:SLP) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
2/3
05:30 pm
slp
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
Medium
Report
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
2/3
05:29 pm
slp
Simulations Plus to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Simulations Plus to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/3
04:05 pm
slp
Simulations Plus to Participate in Upcoming Investor Conferences
Medium
Report
Simulations Plus to Participate in Upcoming Investor Conferences